Technical Analysis for ANIK - Anika Therapeutics Inc.

Grade Last Price % Change Price Change
C 40.78 -1.57% -0.65
ANIK closed down 1.57 percent on Thursday, May 6, 2021, on 53 percent of normal volume.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Flat
Historical ANIK trend table...

Date Alert Name Type % Chg
Fell Below 20 DMA Bearish 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
Earnings Movers Other 0.00%
Crossed Above 20 DMA Bullish -1.57%
Bollinger Band Squeeze Range Contraction -1.57%
Fell Below 20 DMA Bearish 0.17%
New Uptrend Bullish 0.17%
Bollinger Band Squeeze Range Contraction 0.17%
Inside Day Range Contraction 0.17%
Crossed Above 20 DMA Bullish -1.71%
Older End-of-Day Signals for ANIK ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Down 2 % about 14 hours ago
Fell Below 20 DMA about 16 hours ago
Fell Below 10 DMA about 16 hours ago
Fell Below Previous Day's Low about 16 hours ago
20 DMA Support about 17 hours ago
View Earlier Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Anika Therapeutics Inc. Description

Anika Therapeutics, Inc., together with its subsidiaries, develops, manufactures, and commercializes therapeutic products for tissue protection, healing, and repair. Its products are based on hyaluronic acid (HA), a naturally occurring biocompatible polymer found in the body. The company's products include ORTHOVISC, ORTHOVISC mini, and MONOVISC for the treatment of osteoarthritis of the knee and various other joints; Hyalofast, a biodegradable support for human bone marrow mesenchymal stem cells that is used in connection with soft tissue regeneration; Hyalonect, a woven gauze used as a graft wrap; Hyaloss, HYAFF fibers used to mix blood/bone grafts to form a paste for bone regeneration; and Hyaloglide, an ACP gel used in tenolysis treatment. It also provides wound care products that comprise Hyalomatrix and Hyalofill, for treatment of complex wounds, such as burns and ulcers; and Hyalograft 3D and Laserskin scaffolds for use in connection with the regeneration of skin, as well as ELEVESS, an aesthetic dermatology product for facial wrinkles and scar remediation. In addition, the company offers AMVISC, AMVISC Plus, STAARVISC-II, Optivisc, AnikaVisc, and AnikaVisc Plus that are injectable HA products used as viscoelastic agents in ophthalmic surgical procedures, such as cataract extraction and intraocular lens implantation. Further, it provides Hyalobarrier, a post-operative adhesion barrier; INCERT, a HA product for the prevention of spinal post-surgical adhesions; and Merogel, a woven fleece nasal packing, as well as Merogel Injectable, a viscous hydrogel. Additionally, the company offers HYVISC, an injectable HA product used for the treatment of joint dysfunction in horses. Anika Therapeutics, Inc. markets its products directly, as well as through a network of distributors in the United States, Europe, and internationally. Anika Therapeutics, Inc. was founded in 1983 and is headquartered in Bedford, Massachusetts.


Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Acid Laser Bone Stem Cells Ophthalmic Therapeutic Product Dysfunction Therapeutic Products Wound Acids Dermatology Lasers Osteoarthritis Knee Ulcer Healing Bone Marrow Burns Cataract Bone Grafting Mesenchymal Stem Cell Wrinkle Intraocular Lens Scar Therapeutic Treatment Of Osteoarthritis Wound Care Products Hyaluronic Acid Joint Dysfunction Oral And Maxillofacial Surgery

Is ANIK a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 47.47
52 Week Low 27.535
Average Volume 123,350
200-Day Moving Average 37.80
50-Day Moving Average 38.66
20-Day Moving Average 40.84
10-Day Moving Average 40.91
Average True Range 1.41
ADX 25.12
+DI 21.61
-DI 14.02
Chandelier Exit (Long, 3 ATRs ) 39.42
Chandelier Exit (Short, 3 ATRs ) 43.15
Upper Bollinger Band 42.20
Lower Bollinger Band 39.48
Percent B (%b) 0.48
BandWidth 6.68
MACD Line 0.59
MACD Signal Line 0.73
MACD Histogram -0.1465
Fundamentals Value
Market Cap 579.67 Million
Num Shares 14.2 Million
EPS 0.79
Price-to-Earnings (P/E) Ratio 51.42
Price-to-Sales 4.30
Price-to-Book 1.91
PEG Ratio 3.19
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 42.75
Resistance 3 (R3) 42.80 42.19 42.42
Resistance 2 (R2) 42.19 41.69 42.17 42.31
Resistance 1 (R1) 41.49 41.38 41.18 41.44 42.20
Pivot Point 40.88 40.88 40.73 40.85 40.88
Support 1 (S1) 40.17 40.38 39.87 40.12 39.36
Support 2 (S2) 39.56 40.07 39.54 39.25
Support 3 (S3) 38.86 39.56 39.14
Support 4 (S4) 38.81